Shanghai (1)

Gemox Chemotherapy (1)

Intrahepatic Cholangiocarcinoma (1)

Lenvatinib (1)

PD1 Antibody (1)

Recruiting (1)

phase 2/phase 3 (1)

Shanghai Zhongshan Hospital (1)

RenJi Hospital (1)

Shanghai 6th People's Hospital (1)

Shanghai Public Health Clinical Center (1)

Shenzhen University General Hospital (1)

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)

neoadjuvant treatment (1)

drug (1)

Other (1)

Interventional (1)

pd1 antibody

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jul 5, 2021